Luoni, A
Massart, R
Nieratschker, V
Nemoda, Z
Blasi, G http://orcid.org/0000-0003-0878-1131
Gilles, M
Witt, S H
Suderman, M J
Suomi, S J
Porcelli, A
Rizzo, G
Fazio, L
Torretta, S
Rampino, A
Berry, A
Gass, P
Cirulli, F
Rietschel, M
Bertolino, A
Deuschle, M
Szyf, M
Riva, M A
Article History
Received: 1 April 2016
Revised: 11 July 2016
Accepted: 12 September 2016
First Online: 8 November 2016
Competing interests
: MAR reports having received compensation as speaker/consultant from Lundbeck, Otzuka, Sumitomo Dainippon Pharma, Sunovion and Takeda. A Bertolino disclosed consulting fees from Hoffman-La Roche. The remaining authors declare no conflict of interest.